What is the maximum dose of spironolactone?

Maximum Dose of Spironolactone

The maximum dose of spironolactone is 400 mg daily, as indicated by FDA labeling for primary hyperaldosteronism, though the appropriate maximum varies significantly by indication. 1

Maximum Doses by Clinical Indication

Heart Failure (HFrEF)

• Maximum recommended dose: 50 mg daily 2, 1
• Starting dose: 25 mg once daily
• Titration: May increase to 50 mg daily after tolerating 25 mg for adequate duration
• Critical safety parameters:
  • Only initiate if eGFR >30 mL/min/1.73 m² and serum potassium <5.0 mEq/L 2
  • Discontinue if potassium cannot be maintained <5.5 mEq/L 2
  • For eGFR 30-50 mL/min/1.73 m², consider starting at 25 mg every other day 1

Important caveat: While the landmark RALES trial used a mean dose of only 26 mg daily and demonstrated 30% mortality reduction 1, some observational data suggests higher doses (75-300 mg) may be needed for adequate decongestion in advanced heart failure 3, 4. However, guideline-based practice supports the 50 mg maximum for standard heart failure management.

Hypertension

• Maximum dose: 100 mg daily (practical maximum) 1, 5
• FDA labeling states doses >100 mg/day "generally do not provide additional reductions in blood pressure" 1
• Starting dose: 25-100 mg daily in single or divided doses
• Titration interval: Every 2 weeks 1
• Evidence shows no dose-response benefit beyond 50-100 mg 5, 6

Cirrhotic Ascites

• Maximum dose: 400 mg daily 7, 1
• Starting dose: 100 mg daily (range 25-200 mg)
• Must initiate in hospital setting with slow titration 7
• Increase cautiously with ≥72-hour intervals due to long half-life of active metabolites 7
• Threshold for determining medical refractoriness when combined with furosemide 160 mg/day 7

Primary Hyperaldosteronism

• Maximum dose: 400 mg daily 1
• Dose range: 100-400 mg daily
• Used for surgical preparation or long-term maintenance in non-surgical candidates 1
• Lower doses (≤50 mg) may be effective when combined with other antihypertensives, with better tolerability 8

Critical Safety Monitoring

Potassium and renal function monitoring schedule:

• Week 1 after initiation or dose increase
• Week 4 after change
• Every 6 months during stable therapy
• More frequently with clinical instability 2

Adverse Effects Are Dose-Dependent

Gynecomastia risk in men increases dramatically with dose:

• 6.9% at 50 mg/day
• 52.2% at ≥150 mg/day 9

Strategy to minimize sexual side effects:

• Use lowest effective dose (75-100 mg often as effective as 150-300 mg for hypertension) 9
• Consider switching to eplerenone or amiloride for painful gynecomastia 7

Key Clinical Pitfalls

1. Do not exceed 50 mg daily in heart failure unless in specialized settings with intensive monitoring—guideline-based practice stops at 50 mg 2, 1

2. Doses >100 mg for hypertension provide no additional benefit but increase adverse effects 1, 5

3. Never initiate or continue with potassium ≥5.0 mEq/L at baseline or ≥5.5 mEq/L during therapy 2

4. Avoid in eGFR ≤30 mL/min/1.73 m² due to accumulation and hyperkalemia risk 2

5. Allow ≥72 hours between dose adjustments due to long half-life of active metabolites 7